HR Execs on the Move

ChromaDex

www.chromadex.com

 
ChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex`s patent portfolio. ChromaDex delivers Niagen® as the sole active ingredient in its consumer product, Tru Niagen® — available at www.truniagen.com and through partnerships with global retailers and distributors.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.chromadex.com
  • 10900 Wilshire Boulevard Suite 600
    Los Angeles, CA USA 90024
  • Phone: 310.388.6706

Executives

Name Title Contact Details
Brianna Gerber
Chief Financial Officer Profile
Jenny Robles
Director, People Matter(s) Profile
Aron Erickson
Vice President of R&D Profile
Yasmeen Nkrumah-Elie
Global Director of R&D for External Research Profile
Philip Redpath
Director, R&D Profile

Similar Companies

The Fertility Institutes

The Fertility Institutes is a world leading fertility center that offers a variety of fertility services including gender selection, PGD genetic screening, surrogacy, egg donors, IVF, and egg freezing.

Vireo Systems

At Vireo Systems we develop, manufacture and market products and brands that enhance the health of humans and animals. Our company is dedicated to maintaining excellence in all production processes and protecting the environment while delivering safe, ...

Volpara Health

Volpara Health provides an advanced AI software platform that enables a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient`s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. More than thirteen million women across 39 countries have had their breast density assessed by Volpara. The company`s software is installed in approximately 2000 leading facilities worldwide, including top cancer centers in the United States. Volpara Health`s technology has been the subject of more than 300 publications. The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations, including FDA clearance and CE marking.

Paradigm Biodevices

Paradigm Biodevices is a Rockland, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fidelity and Health Int'l Co. Lt

Fidelity & Health Int'l Co. Lt is a Pasadena, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.